Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
Clinical trial NCT04020575 · RECRUITING
Trial details
- NCT number
- NCT04020575
- Sponsor
- Minerva Biotechnologies Corporation
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2025-01-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.